BioCentury
ARTICLE | Financial News

Atriva Therapeutics completes venture financing

February 10, 2017 8:44 PM UTC

On Feb. 7, influenza play Atriva Therapeutics GmbH (Tübingen, Germany) raised €1.5 million ($1.6 million) in the first close of a planned €3 million ($3.2 million) seed round led by Stichting Partici...

BCIQ Company Profiles

Atriva Therapeutics GmbH